Tasly Pharmaceutical Group Co Ltd
SSE:600535
Wall Street
Price Targets
Price Targets Summary
Tasly Pharmaceutical Group Co Ltd
According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 14.24 CNY with a low forecast of 9.6 CNY and a high forecast of 20.54 CNY.
Operating Income
Forecast
Operating Income Estimate
Tasly Pharmaceutical Group Co Ltd
For the last 8 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's operating income is -5%. The projected CAGR for the next 3 years is 12%.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is Tasly Pharmaceutical Group Co Ltd's stock price target?
Price Target
14.24
CNY
According to Wall Street analysts, the average 1-year price target for Tasly Pharmaceutical Group Co Ltd is 14.24 CNY with a low forecast of 9.6 CNY and a high forecast of 20.54 CNY.
What is Tasly Pharmaceutical Group Co Ltd's Revenue forecast?
Projected CAGR
6%
For the last 8 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's revenue is -5%. The projected CAGR for the next 3 years is 6%.
What is Tasly Pharmaceutical Group Co Ltd's Operating Income forecast?
Projected CAGR
12%
For the last 8 years the compound annual growth rate for Tasly Pharmaceutical Group Co Ltd's operating income is -5%. The projected CAGR for the next 3 years is 12%.